CompletedNCT00562861
Citalopram with a mood stabilizer for bipolarity depression
About this title
Read the official source — NCT00562861Medication studyAges 18–64United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.
- Listed locations
- DurhamSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateNovember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 119
- Sponsor
- Tufts Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT00562861
- Official title
Show the full official title
Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Durham
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tufts Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including citalopram + mood stabilizer and placebo + mood stabilizer.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 64 years. Other eligibility criteria applied.
